AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD
|
|
- Eleanore Flowers
- 8 years ago
- Views:
Transcription
1 AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD Bert Wognum Oliver Egeler Caren Grande Ning Yuan Steven Woodside Terry Thomas Allen Eaves STEMCELL Technologies Inc. (Vancouver, Canada)
2 HEMATOPOIETIC COLONY FORMING CELL/UNIT (CFC or CFU) ASSAY Applications in Hematopoietic Stem and Progenitor Cell Transplantation: Assessing Frequency and Quality of hematopoietic Progenitors in Cell Products Quality Control of Cell Therapy Laboratory Procedures Potential Use for Graft Selection CFC content of grafts correlates with : Time to neutrophil engraftment Time to platelet engraftment Overall survival Prasad et al., Blood 112: ; Page et al. J., Biology of Blood and Marrow Transplantation (2011), in press.
3 HEMATOPOIETIC CFC-ASSAY 1. Prepare Cells 2. Add cells to semisolid medium 3. Plate and Incubate 14 days in most media Total CFC, BFU-E, CFU-GM, CFU-GEMM 7 days in selected media Total CFC only 4. Count Colonies
4 VARIABILITY OF CFC-ASSAY RESULTS Intra-laboratory Coefficient of Variation: 10-20% (STEMCELLL: in-house data) Inter-laboratory Coefficient of Variation: ~30% (Spellman et al: Cytotherapy Mar 30) Manual Colony Counting is one Source of Variability in the CFC-Assay Goal: Standardize the CFC-assay on Cord Blood and reduce variability by automating colony identification and enumeration
5 AUTOMATION OF COLONY IDENTIFICATION AND SCORING 7-day CFC-assay: Total colonies 14-day CFC-assay: Total, Erythroid and Myeloid colonies
6 AUTOMATED COLONY DETECTION IN 7-DAY CFC-ASSAY
7 AUTOMATED COLONY DETECTION AND CLASSIFICATION IN 14-DAY CFC-ASSAY Erythroid Myeloid
8 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 7-DAY CFC-ASSAYS ON CB Regression analysis: y=1.02x R 2 = 0.92 N=294 Bias* = -4.0% Data contributing laboratories: StemCell Technologies n=102 3 NMDP-associated CB Banks n=192 Assays were performed in MethoCult Express * Bias = % average difference between manual and automated counts
9 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 14-DAY CFC-ASSAYS ON CB Total CFCs Regression analysis: y=0.98x R 2 = 0.83 N=167 Bias* = -9.0 % Data contributing laboratories: StemCell Technologies n= 62 4 NMDP associated CB Banks: n=105 Assays were performed in MethoCult H4034, H4434 or H4435. * Bias = % average difference between manual and automated counts
10 MANUAL AND AUTOMATED COUNTS SHOW STRONG CORRELATION 14-DAY CFC-ASSAYS ON CB Erythroid Colonies Myeloid Colonies
11 REPRODUCIBILITY OF COLONY COUNTING: which method has lower variability? Coefficient of Variation (CV) of: Manual (microscopic) counts by 3-5 people counting the same cultures 7-day CFC-assay : Overall CV= 11% N=36
12 AUTOMATED COLONY COUNTS ARE MORE REPRODUCIBLE THAN MANUAL COLONY COUNTS Coefficient of Variation (CV) of: Manual (microscopic) counts by 3-5 people counting the same cultures Replicate automated counts of the same cultures imaged repeatedly on 3-5 instruments 7-day CFC-assay : Overall CV= 11% : Overall CV= 5% N=36
13 AUTOMATED COLONY COUNTS ARE MORE REPRODUCIBLE THAN MANUAL COLONY COUNTS Variability of pooled replicate data Manual Automated Total CFC (7 day assay) Total CFC (14 day assay) 11% 5% 12% 5% BFU-E 11% 10% CFU-GM+CFU- GEMM 17% 9%
14 CONCLUSIONS AND FUTURE DIRECTIONS Automated Colony Identification and Counting: 1. Shows good correlation with manual colony counting in 7 day and 14 day CFC-assays on Cord Blood 2. Reduces variability relative to manual colony counting 3. Provides a permanent image record of CFC-assay results 4. Can be modified for specific applications, e.g., CFU-GM enumeration in media without Erythropoietin CFC-assays on other cell sources (BM, MPB, patient samples)
15 ACKNOWLEDGEMENTS STEMCELL Technologies: Research and Development Dept. Instrumentation Group Quality Control Dept. Education & Contract Assay Services Collaborators: Puget Sound Blood Center, Seattle, Washington, USA MD Anderson Cancer Center, Houston, Texas, USA Duke University Medical Center, Durham, North Carolina, USA St. Louis Cord Blood Bank, St. Louis, Missouri, USA Anthony Nolan Trust, Nottingham, UK Vancouver, British Columbia, Canada
16
Automated and Standardized Counting of CFU Assays of Human Hematopoietic Cells
Automated and Standardized Counting of CFU Assays of Human Hematopoietic Cells 2 Automated and Standardized Colony Counting Table of Contents 4 Standardized Counting of Colony-Forming Unit Assays (CFU)
More informationAutomated and Standardized Counting of CFU Assays for Cord Blood Banks
Automated and Standardized Counting of CFU Assays for Cord Blood Banks 2 Automated and Standardized Colony Counting Table of Contents 4 The Colony-Forming Unit (CFU) Assay for Cord Blood Banks 5 The CFU
More informationProliferation/Potency Assays: Is there more to CD34 and CFU?
Proliferation/Potency Assays: Is there more to CD34 and CFU? CBMTG 2012 Laboratory Committee Meeting April 11, 2012 Toronto, ON, Canada Leah Marquez-Curtis CBS-Edmonton OUTLINE I. Rationale and Definitions
More informationPreparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between
Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012 Disclosures: none The problem:
More informationSTEMCELL Quality Control Kits
STEMCELL Quality Control Kits i Table of Contents 1.0 Introduction...1 2.0 Thawing Cells, Plating and Colony Enumeration...2 2.1 Supplies and reagents included in the QC kit...2 2.2 Additional reagents
More informationSaving your baby s s cord blood: Is this good insurance?
Saving your baby s s cord blood: Is this good insurance? 32 th SEMINAR ON PERINATAL MEDICINE CONTROVERSIES IN PERINATAL MEDICINE: EVIDENCE FOR CURRENT PRACTICE Sante Fe, New Mexico Mervin C. Yoder, MD
More informationStephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies Inc., Vancouver, Canada WWW.STEMCELL.
WHITE PAPER Potency Assays for Measuring the Engraftment Potential of Hematopoietic Stem and Progenitor Cells Stephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies
More informationA simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences
Cytotherapy (2001) Vol. 3, No. 6, 429 433 A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences JM Alonso III 1, DM Regan 1, CE
More informationCord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us
More informationPl I enary Tr T anslational Medicine April 30, 2015
Plenary I Translational Medicine April 30, 2015 HBO in Hematopoietic Stem Cell Transplantation: Lessons Learned Omar Aljitawi, MD Hematology/Oncology Hematology and Transplantation (HAT) Laboratory Pathology
More informationLe norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale
Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Topics 1- NetCord-FACT: l organizzazione internazionale ed il suo scopo 2- Le norme di qualità sul bancaggio
More informationProcessing & Utilization of Cord Blood for Transplant
Processing & Utilization of Cord Blood for Transplant 2010-Jan Jan-15 Nicole L. Prokopishyn, PhD HPC Processing Laboratory Director Calgary Laboratory Services Overview Cord Blood Processing Pre-Freeze
More informationTransmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014
FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow
More informationImproved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium
Improved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium Daniel W. Allison, 1 Stacy L. Leugers, 1 Barry J. Pronold, 2 Gary Van Zant, 2 Jenny A. Harrington,
More informationenix Stem Cell Research Assays
HemoGenix enix Stem Cell Research Assays Methylcellulose CFU-Assays For Hematopoietic Cell Processing These are reagents and assays that allow the clonal detection in methylcellulose. Designed for hematopoietic
More informationCell Recovery Sufficient for Adult Transplantation by Additional Cord Blood Collection From Placenta
Cell Recovery Sufficient for Adult Transplantation by Additional Cord Blood Collection From Placenta N. Tsagias, K. Kouzi-Koliakos, D. Hamidi-Alamdari, V. Karagiannis, E. Kostidou, and G. Koliakos ABSTRACT
More informationCord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program
Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs
More informationDie Periphere Blutstammzell- Transplantation
Die Periphere Blutstammzell- Transplantation Martin Körbling DGHO, Stuttgart, Oktober 2012 Der Ursprung des Begriffs Stammzelle Alexander Maximow 1909 A. Maximow, Fol. Haematol. 8;1909:125-134 St. Petersburg
More information1 Materials and methods. 1.1 Materials
Vol. 44 No. 5 SCIENCE IN CHINA (Series C) October 2001 Expansion of CD34 + cells from human umbilical cord blood by FL and/or TPO gene transfected human marrow stromal cell lines ZHANG Yi (Æ Ê), TANG Peixian
More informationBeyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012
Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Massachusetts General Hospital June, 2012 OUTLINE Cell Dose HLA Typing HLA C and KIR HLA Antibodies ABO and Racial/Ethnic
More informationDetecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units
Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Detecting
More informationOptimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation
Bone Marrow Transplantation, (1999) 23, 131 136 1999 Stockton Press All rights reserved 268 3369/99 $12. http://www.stockton-press.co.uk/bmt Optimal timing for processing and cryopreservation of umbilical
More informationPublic Cord Blood Banking at the National Cord Blood Program (NCBP)
Public Cord Blood Banking at the National Cord Blood Program (NCBP) A. Scaradavou, MD Medical Director, National Cord Blood Program, New York Blood Center Associate Attending, Pediatric BMT Memorial Sloan-Kettering
More informationUmbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationCD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia
CD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia Panterne Béatrice Cells and Tissues Coordinator Batch release
More informationHow To Become A Doctor
Page 1 of 8 Rank Name PHS #, Medical Officer, CV cover sheet, Date PROFESSIONAL QUALIFICATIONS 8/97-7/99 Senior Staff Fellow, National Institutes of Health (NIH), Dept. of Transfusion Medicine 7/1995 Board
More informationUMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION
More informationEquality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants
Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,
More informationStem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine
Stem Cells and Inner Ear Cell Regeneration Stefan Heller Stanford University School of Medicine Embryonic stem cells Induced pluripotent stem cells Somatic stem cells 50 µm Derived from the inner cell
More informationCord Blood Market Trends, circa 2014
GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Topic Introduction and Scope The focus of this GEN
More informationFresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport
Cytotherapy (2006) Vol. 8, No. 2, 158/165 Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport V Antonenas 1, F Garvin 1, M Webb 1, M Sartor 2,
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationReview Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units
Stem Cells International Volume 2013, Article ID 463031, 7 pages http://dx.doi.org/10.1155/2013/463031 Review Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units
More information11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont.
History of CBUs First CBU transplant done in 1988 10-CBA providing access to unlicensed cord blood units Using the NMDP IND to access unlicensed cord blood units Amy Hays, Sr. Clinical Research Specialist,
More informationCORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE
CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE JOSÉ MAURO KUTNER, MD MEDICAL DIRECTOR BLOOD BANK Brazil - South America BARCELONA * * SÃO PAULO Brazil - South America Brazil
More informationDetecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units
Patterson et al. Journal of Translational Medicine (2015) 13:94 DOI 10.1186/s12967-015-0434-z RESEARCH Open Access Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions
More informationFiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program
U.S. Department of Health and Human Services Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program Executive Summary The
More informationHematopoietic Stem and Progenitor Cells
MINI-REVIEW Hematopoietic Stem and Progenitor Cells Albertus W. Wognum, PhD Principal Scientist Stephen J. Szilvassy, PhD Director, Hematopoietic Products R&D Introduction Mature blood cells have a finite
More informationCHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation
More informationFetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients
Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant Recipients Filippo Milano, 1 J. Lee Nelson, 1, 2 Colleen Delaney 1,3 1 Clinical Research Division, Fred Hutchinson Cancer Research
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationINFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002
INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation
More informationEquine Stem Cells. Sources, Processing, Expansion, Storage and Shipping
Equine Stem Cells Sources, Processing, Expansion, Storage and Shipping Sean Owens, DVM, Diplomate ACVP Medical Director, UC Davis Veterinary Regenerative Medicine Laboratory What is a Stem Cell and What
More informationProgram Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
More informationGrowth characteristics and expansion of human umbilical cord
Proc. Nati. Acad. Sci. USA Vol. 89, pp. 4109-4113, May 1992 Medical Sciences Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
More informationThe donor search: the best donor or cord blood unit
The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation
More informationEUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases
! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center
More information10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in
More informationOne of the most important recent developments in cancer treatment has been the ability to harvest stem
BIOTECHNOLOGY A Patient-Friendly Approach to Human Cell Transplantation One of the most important recent developments in cancer treatment has been the ability to harvest stem cells from bone marrow or
More informationComparability of Cord Blood Units
Comparability of Cord Blood Units John D. McMannis,, Ph.D. Professor of Cancer Medicine Director, Cell Therapy Laboratory Technical Director, UT MDAnderson Cord Blood Bank Liaison Meeting, Bethesda June
More informationLaura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,
Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'
More informationSTEM CELL THERAPEUTIC OUTCOMES DATABASE
C W Bill Young Cell Transplantation Program STEM CELL THERAPEUTIC OUTCOMES DATABASE BUS06_1ppt Stem Cell Therapeutic and Research Act of 2005 (PL 109-129) 129) Authorizing law, preceded by efforts to:
More informationhematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.
hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.ch Spring water: Manufactured by nature COSTLESS Cord Blood:
More informationAutomated Cord Blood Processing:
TM Automated Cord Blood Processing: A Follow-up to the Pilar Solves Study Comparing the AXP vs the Sepax Cord Blood Processing Systems CHRISTY KIM, PETRA CRAVENS, MINDY WILKE-DOUGLAS AND MITCHEL SIVILOTTI
More informationANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012
ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is
More informationCord Blood: Thawing & Infusion Practical Methods
Cord Blood: Thawing & Infusion Practical Methods Donna M Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Objectives Present variety of product configurations
More informationEnumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood
Application Note Primary Cell Analysis Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Cell Viability Introduction: Bone Marrow, Cord Blood, Stem
More informationStem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationKathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center
Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Discuss Quality dashboards as auditing and Reporting Methods for Quality Management Provide examples
More informationThe Cord Blood Industry and Be The Match
The Cord Blood Industry and Be The Match Arthur Busse Manager of Business Analytics NMDP: Be The Match Sept. 11, 2015 Be The Match Mission Saving Lives with cellular therapy through science, service and
More informationBLOOD COMPONENTS. Liquid storage, shipment, and cryopreservation of cord blood. Allison Hubel, Dale Carlquist, Mary Clay, and Jeff McCullough
Blackwell Science, LtdOxford, UKTRFTransfusion0041-11322004 American Association of Blood BanksApril 2004444Original ArticleLIQUID AND FROZEN STORAGE OF CORD BLOODHUBEL ET AL. BLOOD COMPONENTS Liquid storage,
More informationSponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013
2013 BioArchive Users Meeting Liège, Belgium 23-24 May 2013 Agenda Wednesday 22 May 1730 Arrival Ramada Plaza Hotel Liège Quai Saint-Léonard 36 4000 Liège Belgium 0032 (0)4 228 81 73 Thursday 23 May 0800
More informationProject Lead: Stephen Forman, M.D. PI: Elizabeth Budde, M.D., Ph.D
Phase I study using T cells expressing a CD123-specific chimeric antigen receptor and truncated EGFR for patients with relapsed or refractory acute myeloid leukemia Project Lead: Stephen Forman, M.D. PI:
More informationProstaglandin E2 Enhances Human Cord Blood Stem. Cell Xenotransplants and Shows Long-Term Safety. in Preclinical Nonhuman Primate Transplant Models
Cell Stem Cell, Volume 8 Supplemental Information Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models Wolfram
More informationDONOR VEIN ASSESSMENT FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION: AN INTERNATIONAL SURVEY BY THE ASFA HPC DONOR SUBCOMMITTEE
DONOR VEIN ASSESSMENT FOR HEMATOPOIETIC PROGENITOR CELL COLLECTION: AN INTERNATIONAL SURVEY BY THE ASFA HPC DONOR SUBCOMMITTEE Mandy Flannery O'Leary, M.D., M.P.H. 1,2, Haewon C. Kim, M.D. 3,4, Nancy M.
More informationCord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations
GE Healthcare Proceedings of the Symposium Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations 12 th Annual Meeting of the International Society for
More informationCauses of Anemia in Patients with Heart Failure. Adriaan Voors, MD, PhD, Cardiologist Professor of Cardiology, UMC Groningen, Netherlands
Causes of Anemia in Patients with Heart Failure Adriaan Voors, MD, PhD, Cardiologist Professor of Cardiology, UMC Groningen, Netherlands Background Anemia is common in patients with CHF Prevalence 15 55%
More informationDo you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma
1 Who is the most influential figure in cord blood around the world? What is the biggest challenge to overcome in the use of cord blood as a source of stem cells? We asked 10 leading experts in the cord
More informationDisclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes
Disclosure Equity interest in Genetix Pharm. Inc. Exclusive license of retroviral cell lines from Columbia No direct participation in MDR clinical trials Columbia U. annual reporting FDA Gene Therapy Transfer
More informationUMBILICAL CORD BLOOD, STEM CELL BANKING
UMBILICAL CORD BLOOD, STEM CELL BANKING Dr.Sharad Jain MD Blood Transfusion officer, & I/C Transfusion Medicine NSCB Medical College. Jabalpur.MP. Introduction: Every parent during childbirth DREAMS the
More informationA Cure for Sickle Cell Anemia and Thalassemia
IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology
More informationHematopoietic Stem Cells, Stem Cell Processing, and Transplantation
Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, MD Director, Hemotherapy and Stem Cell Processing Facility E-mail: js2745@columbia.edu A 40-year old man with acute myelogenous
More informationStem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.
Stem cells possess 2 main characteristics: -Long-term self renewal. - They give rise to all types of differentiate cells. Sources of pluripotent stem cells: -The inner cell mass of the blastocyst. - Fetal
More informationCleveland Cord Blood Center Biologics License Application (BLA) Mary J. Laughlin, MD Medical Director
Cleveland Cord Blood Center Biologics License Application (BLA) Mary J. Laughlin, MD Medical Director Background: Cleveland Cord Blood Center A non-profit public cord blood bank. Established in 2007 with
More informationASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Assemblywoman CHARLOTTE VANDERVALK District (Bergen) SYNOPSIS Requires hospitals to provide information to pregnant
More informationThe Power & Potential of Cord Blood
The Power & Potential of Cord Blood Donna Regan, MT(ASCP)SBB, Director St. Louis Cord Blood Bank & Cellular Therapy Laboratory SSM Cardinal Glennon Children s Medical Center September 18, 2013 Objectives
More informationCD34+ CELL ENUMERATION ON FROZEN SAMPLES: VIABILITY ASSESSMENT
CD34+ CELL ENUMERATION ON FROZEN SAMPLES: VIABILITY ASSESSMENT Stradivari Antonio Francesco Lanza Hematology Institute- Cremona Italy ------------ EBMT STWP Chairman ----------- ISTANBUL, EBMT 215 1 CELL
More informationUmbilical Cord Blood: An Alternative Allogeneic Stem Cell Source for Transplantation
Umbilical Cord Blood: An Alternative Allogeneic Stem Cell Source for Transplantation Mary J. Laughlin, MD Associate Professor of Medicine and Pathology Dr. Donald and Ruth Weber Goodman Professor of Innovative
More informationDesign, Operation and Management of GTP/GMP Cell Engineering Facilities
Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based
More informationNAZARETH GENGOZIAN, 2,3,4 ROBERTA J. HILL, 5 MICHAEL R. CAUDLE, 6 AND TIMOTHY J. PANELLA 3
April 15, 1998 GENGOZIAN ET AL. 939 5. Dahlbäck B. Physiological anticoagulation: resistance to protein C and venous thromboembolism. J Clin Invest 1994; 94: 923. 6. Svensson PJ, Dahlbäck B. Resistance
More informationBMC Cell Biology. Open Access. Abstract
BMC Cell Biology BioMed Central Methodology article Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells Tuija Kekarainen 1,2, Sirkka Mannelin 1, Jarmo Laine 1 and
More informationHOUSE BILL REPORT HB 2805
HOUSE BILL REPORT HB 2805 Title: An act relating to umbilical cord blood. As Reported by House Committee On: Health Care & Wellness Appropriations Brief Description: Regarding the collection of umbilical
More informationEconomics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015
Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000
More informationUniversity of Kuwait Faculty of Allied Health Sciences Occupational Therapy Department
University of Kuwait Faculty of Allied Health Sciences Occupational Therapy Department List of Approved Occupational Therapy Graduate Programs for Kuwait University Scholarship United States of America
More informationPr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose
Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of
More informationFACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP
FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP WEDNESDAY 01/07/2015 Morning Parallel Sessions Cord Blood Banking Cellular Therapy/Regenerative Medicine
More informationMy Sister s s Keeper. Science Background Talk
My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating
More informationCord Blood: Research Progress and Future Promise
Cord Blood: Research Progress and Future Promise By Al Staropoli, AABB Contributing Writer Sue Fister found out she had leukemia when she was 50 years old. Doctors suggested a bone marrow transplant as
More informationJeffrey W. Chell, M.D.
Jeffrey W. Chell, M.D. Management Experience 2000 Present National Marrow Donor Program Minneapolis, MN Chief Executive Officer Facilitates over 6,000 Bone Marrow and Stem Cell transplants between volunteer
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationPACT Web Seminar July 19, 2007
PACT Web Seminar July 19, 2007 Phyllis I. Warkentin, MD Professor, Pathology and Pediatrics University of NE Medical Center Medical Director Chairman, Accreditation Program Foundation for the Accreditation
More informationguides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research
infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures
More informationGRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
More information15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com. April 17, 2015.
15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com April 17, 2015 Dear Shareholder, We are experiencing exciting times at HemaCare. Over the course of
More informationChanges to UK NEQAS Leucocyte Immunophenotyping Chimerism Performance Monitoring Systems From April 2014. Uncontrolled Copy
Changes to UK NEQAS Leucocyte Immunophenotyping Chimerism Performance Monitoring Systems From April 2014 Contents 1. The need for change 2. Current systems 3. Proposed z-score system 4. Comparison of z-score
More informationThe Power & Potential of Cord Blood
The Power & Potential of Cord Blood Donna Regan, MT(ASCP)SBB, Director St. Louis Cord Blood Bank & Cellular Therapy Laboratory SSM Cardinal Glennon Children s Medical Center April 30, 2014 Objectives Since
More informationRecommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life
Recommendations to Transplant Centres Performing Cord Blood Transplants Vicki Antonenas Why Choosing the Right Thaw Method Could Save a Patient s Life Lynn O Donnell (USA) 1 The process of receiving, testing
More information